Sagespring Wealth Partners LLC grew its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 26.2% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 785 shares of the biotechnology company’s stock after purchasing an additional 163 shares during the quarter. Sagespring Wealth Partners LLC’s holdings in Axon Enterprise were worth $650,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in AXON. Brighton Jones LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $480,000. GAMMA Investing LLC grew its holdings in Axon Enterprise by 11.8% in the 1st quarter. GAMMA Investing LLC now owns 1,454 shares of the biotechnology company’s stock worth $765,000 after buying an additional 154 shares in the last quarter. Ritholtz Wealth Management grew its holdings in Axon Enterprise by 14.0% in the 1st quarter. Ritholtz Wealth Management now owns 702 shares of the biotechnology company’s stock worth $369,000 after buying an additional 86 shares in the last quarter. Exchange Traded Concepts LLC grew its holdings in Axon Enterprise by 71.5% in the 1st quarter. Exchange Traded Concepts LLC now owns 2,459 shares of the biotechnology company’s stock worth $1,293,000 after buying an additional 1,025 shares in the last quarter. Finally, Optivise Advisory Services LLC bought a new position in Axon Enterprise in the 1st quarter worth approximately $210,000. 79.08% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts recently issued reports on the company. Morgan Stanley set a $885.00 price objective on Axon Enterprise and gave the stock an “overweight” rating in a report on Friday, July 11th. JPMorgan Chase & Co. increased their price objective on Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a report on Thursday, July 17th. Wolfe Research assumed coverage on Axon Enterprise in a report on Monday, July 7th. They issued an “outperform” rating for the company. Bank of America increased their price objective on Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. Finally, Zacks Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 2nd. Fourteen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $841.64.
Axon Enterprise Stock Performance
AXON opened at $652.17 on Friday. The company has a market capitalization of $51.20 billion, a price-to-earnings ratio of 161.03, a price-to-earnings-growth ratio of 25.05 and a beta of 1.41. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. Axon Enterprise, Inc has a 1-year low of $422.38 and a 1-year high of $885.91. The business has a 50 day moving average price of $742.88 and a two-hundred day moving average price of $716.37.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.58. The firm had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm’s revenue for the quarter was up 32.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Research analysts predict that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.
Insider Buying and Selling at Axon Enterprise
In other news, CAO Jennifer H. Mak sold 77 shares of the firm’s stock in a transaction on Monday, September 15th. The stock was sold at an average price of $760.00, for a total transaction of $58,520.00. Following the completion of the sale, the chief accounting officer directly owned 15,003 shares of the company’s stock, valued at $11,402,280. This trade represents a 0.51% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Brittany Bagley sold 5,000 shares of the firm’s stock in a transaction on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the sale, the chief financial officer directly owned 93,592 shares of the company’s stock, valued at approximately $66,813,456.96. This represents a 5.07% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 59,932 shares of company stock worth $45,115,616. 4.40% of the stock is owned by insiders.
About Axon Enterprise
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
- Five stocks we like better than Axon Enterprise
- Basic Materials Stocks Investing
- Salesforce’s Long-Awaited Inflection is Here: Rally On!
- Transportation Stocks Investing
- Rocket Lab USA Receives Wall Street Validation: Time to Buy?
- How to Invest in Insurance Companies: A Guide
- Archer Buys Rival’s Patent Treasure Trove in Strategic Move
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.